INITIATION OF A PHASE 1 DOSE-ESCALATING STUDY OF WEEKLY DIRECT-TO-BRAIN ADMINISTRATION OF SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (MAGIC-G1 STUDY)
Conferences
Desjardins, A; Conlon, K; Gunning, H; Davies, R; Komisarow, J; Cavaliere, R; Zamoryakhin, D
Published in: NEURO-ONCOLOGY
November 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 2022
Volume
24
Start / End Page
79 / 79
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Conlon, K., Gunning, H., Davies, R., Komisarow, J., Cavaliere, R., & Zamoryakhin, D. (2022). INITIATION OF A PHASE 1 DOSE-ESCALATING STUDY OF WEEKLY DIRECT-TO-BRAIN ADMINISTRATION OF SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (MAGIC-G1 STUDY). In NEURO-ONCOLOGY (Vol. 24, pp. 79–79).
Desjardins, Annick, Kelly Conlon, Hannah Gunning, Rhian Davies, Jordan Komisarow, Robert Cavaliere, and Dmitry Zamoryakhin. “INITIATION OF A PHASE 1 DOSE-ESCALATING STUDY OF WEEKLY DIRECT-TO-BRAIN ADMINISTRATION OF SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (MAGIC-G1 STUDY).” In NEURO-ONCOLOGY, 24:79–79, 2022.
Desjardins A, Conlon K, Gunning H, Davies R, Komisarow J, Cavaliere R, et al. INITIATION OF A PHASE 1 DOSE-ESCALATING STUDY OF WEEKLY DIRECT-TO-BRAIN ADMINISTRATION OF SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (MAGIC-G1 STUDY). In: NEURO-ONCOLOGY. 2022. p. 79–79.
Desjardins, Annick, et al. “INITIATION OF A PHASE 1 DOSE-ESCALATING STUDY OF WEEKLY DIRECT-TO-BRAIN ADMINISTRATION OF SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (MAGIC-G1 STUDY).” NEURO-ONCOLOGY, vol. 24, 2022, pp. 79–79.
Desjardins A, Conlon K, Gunning H, Davies R, Komisarow J, Cavaliere R, Zamoryakhin D. INITIATION OF A PHASE 1 DOSE-ESCALATING STUDY OF WEEKLY DIRECT-TO-BRAIN ADMINISTRATION OF SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (MAGIC-G1 STUDY). NEURO-ONCOLOGY. 2022. p. 79–79.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 2022
Volume
24
Start / End Page
79 / 79
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis